Prime Medicine, Inc. (PRME) Operating income 2020–2025
Prime Medicine, Inc. (PRME) annual operating income history from SEC filings — each fiscal year as reported.
-$208.3MFY2025 · since FY2020: -$932,000 → -$208.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$208.3M | -2.9% |
| FY2024 | -$202.5M | +1.1% |
| FY2023 | -$204.8M | -75.7% |
| FY2022 | -$116.5M | -38.0% |
| FY2021 | -$84.5M | -8963.7% |
| FY2020 | -$932,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PRME financial trends
PRME RevenuePRME Net incomePRME Net marginPRME Gross profitPRME Gross marginPRME Operating marginPRME Operating cash flowPRME Free cash flowPRME Capital expendituresPRME Return on equityPRME Stock buybacksPRME Dividends paidPRME Total assetsPRME Total liabilitiesPRME Shareholders’ equityPRME overview →